Abstract
Introduction: Long-term oxygen therapy (LTOT) reduces mortality and improves function in patients with COPD. Guidelines for prescribing oxygen therapy vary; however, all agree that (LTOT) should be considered in patients at risk of developing hypoxemia.
Aims and objectives: To describe prevalence of low SpO2 at rest, post-exercise and self-reported LTOT use amongst primary care COPD patients.
Methods: Baseline data for existing COPD patients (n=1558) from the Birmingham COPD Cohort study were used to describe clinical and demographic characteristics by SpO2 level. “Low SpO2” was defined as ≤92% at rest. We also reported the number of patients experiencing ≥4% SpO2 drop post-exercise, which was a one-minute sit-to-stand test.
Results: 159 (11%) patients had ≤92% resting SpO2. Patients with low SpO2 were more likely to be ever-smokers (p<0.05) and obese (p<0.05) with worse dyspnoea (p<0.001) and lower exercise capacity (adjusted for age, sex, pack-years and GOLD stage; p 0.015). Hospitalisation and exacerbation rates did not differ by SpO2 level. Only 20 (13%) of those patients with low SpO2 at rest had self-reported LTOT.
After exercise, 92 (8%) desaturated >4%, from their resting SpO2; the majority of whom, 64 (70%) had normal SpO2 at baseline.
Conclusion: Within a primary care COPD population, patients with lower SpO2 were more likely to report worse breathlessness, lower exercise capacity, a history of smoking and be obese. Around 13% of patients in this cohort may benefit from LTOT use.
- Copyright ©the authors 2016